Hospital
Franciscan Health Rensselaer, INC.
Franciscan Health Rensselaer, INC. was paid $4.16M by Medicaid between Jan 2018 and Nov 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoFRANCISCAN HEALTH RENSSELAER, INC.
RENSSELAER, IN 47978
RENSSELAER, IN 47978
33aNPI1932589173assigned 06/03/2015
33bProvider typeCritical Access Hospital
28Total paid$4.16M
24GClaims66,584
24DCodes billed60
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#14 of 26
Median peer was paid$4.16M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,006 | $190K | |
| 2019 | 5,014 | $300K | |
| 2020 | 5,460 | $410K | |
| 2021 | 10,107 | $749K | |
| 2022 | 16,184 | $1.10M | |
| 2023 | 14,148 | $880K | |
| 2024incomplete | 8,665 | $531K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 10,915 | 9,408 | $1.55M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 8,065 | 6,554 | $1.29M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 1,234 | 985 | $161K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.7% | 2,148 | 1,794 | $153K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.6% | 2,489 | 1,866 | $148K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.8% | 2,080 | 1,341 | $73K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 725 | 612 | $69K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 388 | 345 | $62K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 774 | 677 | $59K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 768 | 619 | $56K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 351 | 290 | $49K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 2,371 | 591 | $48K |
48 more codes
| 80053 | Comprehensive metabolic panel | 1.1% | 6,608 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,156 | $40K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,193 | $40K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 633 | $38K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 735 | $29K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 334 | $29K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 290 | $27K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,106 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 384 | $19K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,375 | $19K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 259 | $18K |
| 92526 | <1% | 220 | $16K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 41 | $15K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 694 | $13K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 191 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 309 | $8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 321 | $8K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 266 | $7K |
| 99218 | <1% | 42 | $5K | |
| 81025 | <1% | 547 | $4K | |
| 81001 | <1% | 1,539 | $3K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 102 | $3K |
| 97162 | <1% | 51 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 430 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 18 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 59 | $2K |
| 85730 | <1% | 378 | $1K | |
| 84484 | <1% | 154 | $1K | |
| 80061 | Lipid panel | <1% | 97 | $854.28 |
| 85610 | <1% | 338 | $677.18 | |
| 83690 | <1% | 134 | $488.09 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $470.89 |
| 87430 | <1% | 58 | $413.05 | |
| 83735 | <1% | 69 | $343.64 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 61 | $249.38 |
| 81003 | <1% | 211 | $241.73 | |
| 87040 | <1% | 25 | $239.44 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $232.19 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 30 | $177.99 |
| 82077 | <1% | 12 | $138.16 | |
| 81000 | <1% | 30 | $82.91 | |
| 87081 | <1% | 15 | $74.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 515 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 25 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 12 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 140 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 25 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILSON, TERRANCE (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Franciscan Health Lafayette | Lafayette, IN | $38.56M |
| Franciscan Health Crawfordsville | Crawfordsville, IN | $13.47M |
| Franciscan Health Lafayette | Lafayette, IN | $8.81M |
| Franciscan Health Rensselaer, INC. | Brook, IN | $177K |
| Franciscan Health Rensselaer, INC. | Wheatfield, IN | $97K |
| Franciscan Health Lafayette | Lafayette, IN | $28K |
| Franciscan Health Lafayette | Lafayette, IN | $903.92 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.